<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38932418</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>20</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Booster Vaccination Status and Long COVID in the United States: A Nationally Representative Cross-Sectional Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">688</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12060688</ELocationID><Abstract><AbstractText>Early studies have found that the initial COVID-19 vaccination series was protective against severe symptoms and long COVID. However, few studies have explored the association of booster doses on severe disease outcomes and long COVID. This cross-sectional analysis used data from the 2022 US National Health Interview Survey data to investigate how vaccination status correlates with COVID-19 infection severity and long COVID among previously infected individuals. Participants were categorized into three groups: those who had received at least one booster, those with only the initial complete vaccination series, and those with either an incomplete series or no vaccinations. Out of 9521 survey respondents who reported a past positive COVID-19 test, 51.2% experienced moderate/severe infections, and 17.6% experienced long COVID. Multivariable regression models revealed that receiving at least one booster shot was associated with lower odds of experiencing moderate/severe symptoms (aOR = 0.78, <i>p</i> &lt; 0.001) compared to those unvaccinated or with an incomplete series. Additionally, having at least one booster reduced long COVID odds by 24% (aOR = 0.76, <i>p</i> = 0.003). Completing only the primary vaccine series did not significantly decrease the likelihood of severe illness or long COVID. These findings support the continued promotion of booster vaccinations to mitigate long COVID risks in vulnerable populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romeiser</LastName><ForeName>Jamie L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Public Health and Preventive Medicine, Upstate Medical University, 766 Irving Ave., Syracuse, NY 13210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoeneck</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Public Health and Preventive Medicine, Upstate Medical University, 766 Irving Ave., Syracuse, NY 13210, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">booster vaccination</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">severe infection</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38932418</ArticleId><ArticleId IdType="pmc">PMC11209278</ArticleId><ArticleId IdType="doi">10.3390/vaccines12060688</ArticleId><ArticleId IdType="pii">vaccines12060688</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feikin D.R., Abu-Raddad L.J., Andrews N., Davies M.-A., Higdon M.M., Orenstein W.A., Patel M.K. Assessing Vaccine Effectiveness against Severe COVID-19 Disease Caused by Omicron Variant. Report from a Meeting of the World Health Organization. Vaccine. 2022;40:3516&#x2013;3527. doi: 10.1016/j.vaccine.2022.04.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.04.069</ArticleId><ArticleId IdType="pmc">PMC9058052</ArticleId><ArticleId IdType="pubmed">35595662</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.-Z., Kuan C.-C. Vaccination to Reduce Severe COVID-19 and Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Eur. Rev. Med. Pharmacol. Sci. 2022;26:1770&#x2013;1776.</Citation><ArticleIdList><ArticleId IdType="pubmed">35302230</ArticleId></ArticleIdList></Reference><Reference><Citation>Adil M.T., Rahman R., Whitelaw D., Jain V., Al-Taan O., Rashid F., Munasinghe A., Jambulingam P. SARS-CoV-2 and the Pandemic of COVID-19. Postgrad. Med. J. 2021;97:110&#x2013;116. doi: 10.1136/postgradmedj-2020-138386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138386</ArticleId><ArticleId IdType="pmc">PMC10016996</ArticleId><ArticleId IdType="pubmed">32788312</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzberger B., Buder F., Lampl B., Ehrenstein B., Hitzenbichler F., Holzmann T., Schmidt B., Hanses F. Epidemiology of SARS-CoV-2. Infection. 2021;49:233&#x2013;239. doi: 10.1007/s15010-020-01531-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01531-3</ArticleId><ArticleId IdType="pmc">PMC7543961</ArticleId><ArticleId IdType="pubmed">33034020</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Number of COVID-19 Cases Reported to WHO.  [(accessed on 5 January 2024)].  Available online:  https://data.who.int/dashboards/covid19/cases?n=c.</Citation></Reference><Reference><Citation>WHO United States of America Situation.  [(accessed on 2 December 2023)].  Available online:  https://covid19.who.int/region/amro/country/us.</Citation></Reference><Reference><Citation>United Health Foundation . Annual Report 2022. American Public Health Association; Washington, DC, USA: 2022.</Citation></Reference><Reference><Citation>Ahmad F.B., Cisewski J.A., Xu J., Anderson R.N. COVID-19 Mortality Update&#x2014;United States, 2022. MMWR Morb. Mortal. Wkly. Rep. 2023;72:493&#x2013;496. doi: 10.15585/mmwr.mm7218a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7218a4</ArticleId><ArticleId IdType="pmc">PMC10168601</ArticleId><ArticleId IdType="pubmed">37141157</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated with Post-COVID-19 Condition: A Systematic Review and Meta-Analysis. JAMA Intern. Med. 2023;183:566. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public. Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R.H., Santillana M., Ognyanova K., Safarpour A., Lunz Trujillo K., Simonson M.D., Green J., Quintana A., Druckman J., Baum M.A., et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw. Open. 2022;5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock M.D., Chew R.F., Preiss A.J., Hadley E.C., Redfield S., McMurry J.A., Leese P.J., Girvin A.T., Crosskey M., Zhou A.G., et al. Long COVID Risk and Pre-COVID Vaccination in an EHR-Based Cohort Study from the RECOVER Program. Nat. Commun. 2023;14:2914. doi: 10.1038/s41467-023-38388-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford N.D., Slaughter D., Edwards D., Dalton A., Perrine C., Vahratian A., Saydah S. Long COVID and Significant Activity Limitation Among Adults, by Age&#x2014;United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb. Mortal. Wkly. Rep. 2023;72:866&#x2013;870. doi: 10.15585/mmwr.mm7232a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective Effect of COVID-19 Vaccination against Long COVID Syndrome: A Systematic Review and Meta-Analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 Vaccination on the Risk of Developing Long-COVID and on Existing Long-COVID Symptoms: A Systematic Review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Valdes A.M., Polidori L., Antonelli M., Penamakuri S., Nogal A., Louca P., May A., Figueiredo J.C., Hu C., et al. Symptom Prevalence, Duration, and Risk of Hospital Admission in Individuals Infected with SARS-CoV-2 during Periods of Omicron and Delta Variant Dominance: A Prospective Observational Study from the ZOE COVID Study. Lancet. 2022;399:1618&#x2013;1624. doi: 10.1016/S0140-6736(22)00327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemaitelly H., Ayoub H.H., Tang P., Coyle P., Yassine H.M., Al Thani A.A., Al-Khatib H.A., Hasan M.R., Al-Kanaani Z., Al-Kuwari E., et al. Long-Term COVID-19 Booster Effectiveness by Infection History and Clinical Vulnerability and Immune Imprinting: A Retrospective Population-Based Cohort Study. Lancet Infect. Dis. 2023;23:816&#x2013;827. doi: 10.1016/S1473-3099(23)00058-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00058-0</ArticleId><ArticleId IdType="pmc">PMC10079373</ArticleId><ArticleId IdType="pubmed">36913963</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Health Statistics National Health Interview Survey.  [(accessed on 15 August 2023)];2022  Available online:  https://www.cdc.gov/nchs/nhis/2022nhis.htm.</Citation></Reference><Reference><Citation>Division of Health Interview Statistics National Center for Health Statistics Hyattsville, Maryland National Health Interview Survey  2022 Survey Description.  [(accessed on 15 January 2023)]; Available online:  ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2022/srvydesc-508.pdf.</Citation></Reference><Reference><Citation>Romeiser J.L., Morley C.P., Singh S.M. COVID-19 Symptom Load as a Risk Factor for Chronic Pain: A National Cross-Sectional Study. PLoS ONE. 2023;18:e0287554. doi: 10.1371/journal.pone.0287554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0287554</ArticleId><ArticleId IdType="pmc">PMC10289324</ArticleId><ArticleId IdType="pubmed">37352207</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Effect of Covid-19 Vaccination on Long Covid: Systematic Review. BMJ Med. 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Piernas C., Patone M., Astbury N.M., Gao M., Sheikh A., Khunti K., Shankar-Hari M., Dixon S., Coupland C., Aveyard P., et al. Associations of BMI with COVID-19 Vaccine Uptake, Vaccine Effectiveness, and Risk of Severe COVID-19 Outcomes after Vaccination in England: A Population-Based Cohort Study. Lancet Diabetes Endocrinol. 2022;10:571&#x2013;580. doi: 10.1016/S2213-8587(22)00158-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00158-9</ArticleId><ArticleId IdType="pmc">PMC9246477</ArticleId><ArticleId IdType="pubmed">35780805</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavanaugh A.M., Spicer K.B., Thoroughman D., Glick C., Winter K. Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination&#x2014;Kentucky, May&#x2013;June 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1081&#x2013;1083. doi: 10.15585/mmwr.mm7032e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7032e1</ArticleId><ArticleId IdType="pmc">PMC8360277</ArticleId><ArticleId IdType="pubmed">34383732</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeraus W., Stuurman A.L., Durukal I., Conde-Sousa E., Lee A., Maria A.S., Furtado B.E., Ouwens M., Gray C.M., Valverde D.A., et al. COVID-19 Vaccine Booster Doses Provide Increased Protection against COVID-19 Hospitalization Compared with Previously Vaccinated Individuals: Interim Findings from the REFORCO-Brazil Real-World Effectiveness Study during Delta and Omicron. Vaccine. 2023;41:6366&#x2013;6378. doi: 10.1016/j.vaccine.2023.08.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.08.085</ArticleId><ArticleId IdType="pubmed">37704499</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A.R., Kobayashi T., Callado G.Y., Pardo I., Gutfreund M.C., Hsieh M.K., Lin V., Alsuhaibani M., Hasegawa S., Tholany J., et al. The Effectiveness of COVID-19 Vaccine in the Prevention of Post-COVID Conditions: A Systematic Literature Review and Meta-Analysis of the Latest Research. Antimicrob. Steward. Healthc. Epidemiol. 2023;3:e168. doi: 10.1017/ash.2023.447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2023.447</ArticleId><ArticleId IdType="pmc">PMC10644173</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A.R., Sampaio V.S., Ozahata M.C., Lopes R., Brito A.F., Bragatte M., Kalil J., Miraglia J.L., Malheiro D.T., Guozhang Y., et al. Risk Factors for Long Coronavirus Disease 2019 (Long COVID) among Healthcare Personnel, Brazil, 2020&#x2013;2022. Infect. Control Hosp. Epidemiol. 2023;44:1972&#x2013;1978. doi: 10.1017/ice.2023.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2023.95</ArticleId><ArticleId IdType="pmc">PMC10755155</ArticleId><ArticleId IdType="pubmed">37272468</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328:676. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaichana U., Man K.K.C., Chen A., Wong I.C.K., George J., Wilson P., Wei L. Definition of Post&#x2013;COVID-19 Condition Among Published Research Studies. JAMA Netw. Open. 2023;6:e235856. doi: 10.1001/jamanetworkopen.2023.5856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5856</ArticleId><ArticleId IdType="pmc">PMC10077105</ArticleId><ArticleId IdType="pubmed">37017970</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan L., Veruttipong D., Shaw J.G., Levy N., Edwards L., Winget M. Relationship of Socio-Demographics, Comorbidities, Symptoms and Healthcare Access with Early COVID-19 Presentation and Disease Severity. BMC Infect. Dis. 2021;21:40. doi: 10.1186/s12879-021-05764-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05764-x</ArticleId><ArticleId IdType="pmc">PMC7794633</ArticleId><ArticleId IdType="pubmed">33421991</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Peyser N.D., Lin F., Knight S.J., Djibo A., Khatib R., Kitzman H., O&#x2019;Brien E., Williams N., et al. Factors Associated with Long COVID Symptoms in an Online Cohort Study. Open Forum Infect. Dis. 2023;10:ofad047. doi: 10.1093/ofid/ofad047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad047</ArticleId><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs E.T., Cordova-Marks F.M., Farland L.V., Ernst K.C., Andrews J.G., Vu S., Heslin K.M., Catalfamo C., Chen Z., Pogreba-Brown K. Understanding Low COVID-19 Booster Uptake among US Adults. Vaccine. 2023;41:6221&#x2013;6226. doi: 10.1016/j.vaccine.2023.08.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.08.080</ArticleId><ArticleId IdType="pubmed">37666694</ArticleId></ArticleIdList></Reference><Reference><Citation>Neely S.R., Hao F. Breakthrough COVID-19 Infections and Perceived Vaccine Effectiveness. Vaccine. 2023;41:7689&#x2013;7694. doi: 10.1016/j.vaccine.2023.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.11.032</ArticleId><ArticleId IdType="pubmed">37996290</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein C., Nassereldine H., Sorensen R.J.D., Amlag J.O., Bisignano C., Byrne S., Castro E., Coberly K., Collins J.K., Dalos J., et al. Past SARS-CoV-2 Infection Protection against Re-Infection: A Systematic Review and Meta-Analysis. Lancet. 2023;401:833&#x2013;842. doi: 10.1016/S0140-6736(22)02465-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02465-5</ArticleId><ArticleId IdType="pmc">PMC9998097</ArticleId><ArticleId IdType="pubmed">36930674</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordstr&#xf6;m P., Ballin M., Nordstr&#xf6;m A. Risk of SARS-CoV-2 Reinfection and COVID-19 Hospitalisation in Individuals with Natural and Hybrid Immunity: A Retrospective, Total Population Cohort Study in Sweden. Lancet Infect. Dis. 2022;22:781&#x2013;790. doi: 10.1016/S1473-3099(22)00143-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00143-8</ArticleId><ArticleId IdType="pmc">PMC8971363</ArticleId><ArticleId IdType="pubmed">35366962</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky J.P., Govindarajulu U., Bagiella E., Goswami R., Kale M., Campbell K.N., Meliambro K., Chen Z., Aberg J.A., Lin J.J. Association of Vaccination with the Persistence of Post-COVID Symptoms. J. Gen. Intern. Med. 2022;37:1748&#x2013;1753. doi: 10.1007/s11606-022-07465-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07465-w</ArticleId><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayyerabadi M., Fourcade L., Joshi S.A., Chandrasekaran P., Chakravarti A., Mass&#xe9; C., Paul M.-L., Houle J., Boubekeur A.M., DuSablon C., et al. Vaccination after Developing Long COVID: Impact on Clinical Presentation, Viral Persistence, and Immune Responses. Int. J. Infect. Dis. 2023;136:136&#x2013;145. doi: 10.1016/j.ijid.2023.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.09.006</ArticleId><ArticleId IdType="pubmed">37717649</ArticleId></ArticleIdList></Reference><Reference><Citation>Limbu Y.B., Gautam R.K. The Determinants of COVID-19 Vaccination Intention: A Meta-Review. Front. Public Health. 2023;11:1162861. doi: 10.3389/fpubh.2023.1162861.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1162861</ArticleId><ArticleId IdType="pmc">PMC10291626</ArticleId><ArticleId IdType="pubmed">37377544</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprengholz P., Betsch C. Previous SARS-CoV-2 Infection Is Linked to Lower Vaccination Intentions. J. Med. Virol. 2021;93:6456&#x2013;6457. doi: 10.1002/jmv.27221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27221</ArticleId><ArticleId IdType="pmc">PMC8427113</ArticleId><ArticleId IdType="pubmed">34289169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobierajski T., Rzymski P., Wanke-Rytt M. Impact of the COVID-19 Pandemic on Attitudes toward Vaccination: Representative Study of Polish Society. Vaccines. 2023;11:1069. doi: 10.3390/vaccines11061069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11061069</ArticleId><ArticleId IdType="pmc">PMC10303243</ArticleId><ArticleId IdType="pubmed">37376458</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Lin F., Peyser N.D., Isasi C., Carton T.W., Henrich T.J., Deeks S.G., Olgin J.E., Pletcher M.J., et al. Association of Nirmatrelvir for Acute SARS-CoV-2 Infection with Subsequent Long COVID Symptoms in an Observational Cohort Study. J. Med. Virol. 2024;96:e29333. doi: 10.1002/jmv.29333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29333</ArticleId><ArticleId IdType="pmc">PMC10786003</ArticleId><ArticleId IdType="pubmed">38175151</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Association of Treatment with Nirmatrelvir and the Risk of Post&#x2013;COVID-19 Condition. JAMA Intern. Med. 2023;183:554. doi: 10.1001/jamainternmed.2023.0743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng L.N., Bonilla H., Hedlin H., Jacobson K.B., Tian L., Jagannathan P., Yang P.C., Subramanian A.K., Liang J.W., Shen S., et al. Nirmatrelvir-Ritonavir and Symptoms in Adults with Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial. JAMA Intern. Med. 2024 doi: 10.1001/jamainternmed.2024.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2024.2007</ArticleId><ArticleId IdType="pmc">PMC11161857</ArticleId><ArticleId IdType="pubmed">38848477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang S., Earl S., Clarke J., Zakaria D., Demers A., Aziz S. Experiences of Canadians with Long-Term Symptoms Following COVID-19. Statistics Canada; Ottawa, ON, Canada: 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>